Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Cerebellar Degeneration
NCT00034242Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Apr 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cerebellar degeneration comparing IVIG with Placebo (2 arms). Primary endpoint: NINDS Ataxia Rating Scale. Started Apr 2002; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
Cerebellar degeneration
Beyond the preview
Go deeper on NCT00034242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034242.